Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination in a high-risk national population
Background: Breakthrough infections after SARS-CoV-2 infection have been reported. Clinical outcomes among persons with breakthrough infection are not known. Methods: We retrospectively identified all Veterans with a confirmed SARS-CoV-2 infection >14 days after the second dose of either Pfizer-B...
Main Authors: | Adeel A. Butt, Peng Yan, Obaid S. Shaikh, Florian B. Mayr |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-10-01
|
Series: | EClinicalMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537021003977 |
Similar Items
-
Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination
by: Adeel A. Butt, MBBS, MS, et al.
Published: (2021-09-01) -
Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine
by: Luisa F. Duarte, et al.
Published: (2021-09-01) -
Severe SARS-CoV-2 Breakthrough Reinfection With Delta Variant After Recovery From Breakthrough Infection by Alpha Variant in a Fully Vaccinated Health Worker
by: Jayanthi Shastri, et al.
Published: (2021-08-01) -
The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data
by: Aharona Glatman-Freedman, et al.
Published: (2021-10-01) -
Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed Patients
by: Xufang Deng, et al.
Published: (2021-09-01)